Baxter International Inc (NYSE: BAX)’s stock price has plunge by 3914675relation to previous closing price of 29.99. Nevertheless, the company has seen a -0.75% plunge in its stock price over the last five trading sessions. businesswire.com reported 2025-06-24 that DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter’s commitment to transparent reporting and provides updates on the company’s 2030 Corporate Responsibility Commitment and Goals,1 which strive to create a more sustainable and responsible business model. “Baxter’s Mission to Save and Sustain Lives inspires our work every day and has remained a guiding forc.
Is It Worth Investing in Baxter International Inc (NYSE: BAX) Right Now?
Additionally, the 36-month beta value for BAX is 0.61. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 11 rating it as “hold,” and 1 rating it as “sell.”
The public float for BAX is 508.69M and currently, short sellers hold a 3.08% ratio of that float. The average trading volume of BAX on June 25, 2025 was 4.14M shares.
BAX’s Market Performance
BAX’s stock has seen a -0.75% decrease for the week, with a 1.06% rise in the past month and a -8.96% fall in the past quarter. The volatility ratio for the week is 1.04%, and the volatility levels for the past 30 days are at 1.67% for Baxter International Inc The simple moving average for the past 20 days is 0.34% for BAX’s stock, with a -6.99% simple moving average for the past 200 days.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with Goldman repeating the rating for BAX by listing it as a “Buy.” The predicted price for BAX in the upcoming period, according to Goldman is $42 based on the research report published on February 26, 2025 of the current year 2025.
Barclays gave a rating of “Overweight” to BAX, setting the target price at $39 in the report published on February 20th of the current year.
BAX Trading at 0.96% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.45% of loss for the given period.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- -0.03 for the present operating margin
- 0.36 for the gross margin
The net margin for Baxter International Inc stands at -0.05. The total capital return value is set at -0.02. Equity return is now at value -8.96, with -2.78 for asset returns.
Based on Baxter International Inc (BAX), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.06. The debt to equity ratio resting at 1.46. The interest coverage ratio of the stock is -1.07.
Currently, EBITDA for the company is 1.12 billion with net debt to EBITDA at 12.39. When we switch over and look at the enterprise to sales, we see a ratio of 1.99. The receivables turnover for the company is 7.22for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.02.
Conclusion
In conclusion, Baxter International Inc (BAX) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
